Bull & Bear

Bull and Bear

Verdict: Avoid — a 12x multiple on earnings that have never once become cash, inside a freshly-listed, promoter-controlled shell, is a trap until the cash proves otherwise. Both advocates agree on the facts: a genuinely large, contracted ₹113,379 mn order book and a recapitalised balance sheet on one side [1]; three straight years of reported profit against negative cumulative operating cash on the other. The entire debate reduces to one question — does the reported profit convert to cash, or is it an accounting construct that re-rates toward book? The bull's offsets are real but each is a promise (FY2028 cash-positive, an asset-light pivot, a ramp to 10 GWh), while the bear's central charge is an observed track record. Until the September 2026 working-capital print and the H1 FY2027 result settle that question with actual collections, the asymmetry favours waiting, not owning.

Bull Case

The bull's three sharpest points survive; the standalone "cheapest in the peer set" argument is dropped because cheapness is downstream of the very cash question in dispute. Pace owns India's largest cell-to-container battery line and is racing to 10 GWh of operational capacity by October 2026, with a ₹113,379 mn executable order book equal to 4.3x FY2026 revenue and 78% energy — multi-year volume that is contracted, not hoped for [1][2], validated when L and T awarded a 250 MWh order in January 2026 after a formal evaluation [3]. The cash drain, the bull argues, is a falsifiable timing gap — a deliberate ₹540 cr lithium-cell pre-buy plus Q4-concentrated milestone billing — with management committing to FY2028 operating-cash-positive [4]. And the balance sheet has been recapitalised: the October 2025 IPO doubled equity to ₹22,522 mn, the rating rose from BBB- to A- and full-year finance cost roughly halved to ₹598 mn from ₹1,152 mn [5], with management pledging no further capital-heavy Build-Own-Operate projects without external capital and a pivot to cash-generative product BESS [6].

Sources: bull points sourced as cited above — Q4 and FY2026 Investor Presentation [1][2]; Q4 and FY2026 earnings call [3][4][5][6].

Bull target: ₹290 over 24 months, set at ~13.3x FY2028E EPS of ₹21.8 (street consensus), cross-checked against management's FY2028 revenue guidance of ₹40,000–42,000 mn at a 10–11% PAT margin [7] — a modest re-rating above the single sell-side target of ₹263 once cash conversion is proven. The primary catalyst is the H1 FY2027 result (around November 2026) showing the trade-receivable book shrinking and operating cash turning positive. The bull's own disconfirming signal is honest: a second consecutive deeply negative operating-cash year — another ~₹5,000 mn-plus deficit in FY2027 — would prove the reported profit is not real cash.

Bear Case

The bear's three sharpest points survive; the standalone "growth destroys capital" point is folded into the capital-efficiency tension below. First, the profit has never become cash: across FY2024–FY2026 Pace booked ₹7,940 mn of cumulative net profit yet generated negative ₹8,790 mn of cumulative operating cash, with FY2026 OCF of negative ₹9,169 mn against ₹3,070 mn of reported profit — and FY2024's lone positive cash year was funded by a payables stretch, not collections (derived from reported FY2024–FY2026 financials). Second, the earnings are increasingly a recognition build: EPC is booked over-time, the parent books construction margin selling to its own consolidated BOO SPVs, a new ₹5,570 mn finance-lease receivable recognises a decade of cash up front, receivables were relabelled current-to-non-current in the first post-listing accounts, and the auditor (CARO) flagged for three straight years that lender filings did not agree with the books — with FY2026 trade receivables standing at ₹2,442 cr against a ₹540 cr inventory build [8]. Third, the governance setting suppresses rather than surfaces the risk: promoters hold ~69.5%, the founder is combined Chairman-and-MD sitting on the audit committee that approves related-party deals, ~₹1,355.84 mn of EPC was routed to promoter-linked Lanarsy Infra in FY2025 [11], and the six-month lock-in expired around April 2026, releasing supply into a thin ~30.5% float.

Sources: cash-flow and accrual figures derived from reported FY2024–FY2026 financials (Forensic and Financials tabs); FY2026 receivables and inventory [8]; promoter-linked Lanarsy EPC related-party transaction [11].

Bear downside: ₹110 over 12–18 months (~40% below the ₹181.82 close of 19 June 2026), set by a de-rating toward book — book value per share is ~₹104, and a company that has converted zero cumulative profit to cash over its entire listed life does not deserve a premium to book; ₹110 is ~1.05x book, or ~7x FY27E EPS. The stock already touched ₹141.7 in March 2026 on exactly this fear. The primary trigger is the H1 FY2027 result: if receivables are still climbing and operating cash is still deeply negative, it refutes the cash-conversion turn that underpins the entire valuation. The cover signal is symmetric and clean — a sustained turn to positive operating cash with like-for-like DSO (including non-current and finance-lease receivables) falling toward ~150 days.

The Real Debate

Every row below is the same fact read two ways — not two unrelated facts. The shared facts are page-traced: the FY2026 receivable and inventory position [8], management's working-capital and FY2028 commitment [4], the ROCE step-down and balance-sheet ratios [9], the BOO SPV economics [10], and the promoter-linked related-party flow [11].

Sources: shared facts traced to the Q4 and FY2026 earnings call [8][4][10], the Q4 and FY2026 presentation [9], and the Red Herring Prospectus [11].

Verdict

Avoid. The bear carries more weight because its central charge is a fact, not a forecast: across its entire listed and pre-listed life Pace has booked roughly ₹7,940 mn of profit and negative ₹8,790 mn of operating cash, and the single most important tension — cash conversion — is decided not by an argument but by collections that have not yet appeared [8]. Governance and earnings-quality concerns — a promoter-controlled board, a combined Chairman-MD on the related-party-approving audit committee, intra-group EPC margin, and a finance-lease receivable that books a decade of cash up front — compound the problem, and a low return on the capital being deployed (a 12–13% BOO IRR, ROCE halved to 14.3%) means the "cheap on earnings" case has little margin for error [9][10]. The bull could still be right: the ₹113,379 mn order book is genuinely contracted and externally validated by L and T, the IPO removed near-term solvency risk (net debt/equity 0.09x), and management has publicly staked its credibility on an FY2028 cash-positive turn and an asset-light pivot [1][4] — if the September 2026 working-capital print confirms the turn, the same 12x multiple re-rates quickly. The condition that would change this verdict to Lean Long is concrete: a clean, sustained turn to positive operating cash with like-for-like DSO (including the non-current and finance-lease buckets) falling toward ~150 days. The durable thesis breaker is whether reported profit ever becomes cash; the near-term evidence marker that previews it is the H1 FY2027 receivable trajectory and OCF sign. Until that evidence exists, this is a stock to track, not to own.